Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Cannabis Bioscience International Holdings (CBIH) EPS (Weighted Average and Diluted) (2022 - 2025)

Cannabis Bioscience International Holdings' EPS (Weighted Average and Diluted) history spans 3 years, with the latest figure at -$0.0 for Q4 2025.

  • For Q4 2025, EPS (Weighted Average and Diluted) fell 22.28% year-over-year to -$0.0; the TTM value through Nov 2025 reached -$0.0, up 78.26%, while the annual FY2025 figure was -$0.0, 16.67% up from the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2025 was -$0.0 at Cannabis Bioscience International Holdings, down from -$0.0 in the prior quarter.
  • Across five years, EPS (Weighted Average and Diluted) topped out at -$0.0 in Q3 2024 and bottomed at -$0.0 in Q1 2023.
  • The 3-year median for EPS (Weighted Average and Diluted) is -$0.0 (2025), against an average of -$0.0.
  • The largest annual shift saw EPS (Weighted Average and Diluted) skyrocketed 65.0% in 2024 before it tumbled 50.0% in 2025.
  • A 3-year view of EPS (Weighted Average and Diluted) shows it stood at -$0.0 in 2023, then grew by 20.0% to -$0.0 in 2024, then decreased by 22.28% to -$0.0 in 2025.
  • Per Business Quant, the three most recent readings for CBIH's EPS (Weighted Average and Diluted) are -$0.0 (Q4 2025), -$0.0 (Q3 2025), and -$0.0 (Q2 2025).